7Baggers
 Xenon Pharmaceuticals Hits Day High with Strong 9.94% Intraday Surge  Markets Mojo Wed, 01 Oct 2025 18:33:30 GMT
 published on: 2025-10-01 07:26:08  newser.com Wed, 01 Oct 2025 12:26:08 GMT
 Stocks Generating Improved Relative Strength: Xenon Pharmaceuticals  Investor's Business Daily Wed, 01 Oct 2025 07:00:00 GMT
 Xenon Announces Upcoming Investor Webinar to Discuss  GlobeNewswire Fri, 26 Sep 2025 05:32:33 GMT
 Why Xenon Pharmaceuticals’ Stock is Climbing  TipRanks Wed, 17 Sep 2025 07:00:00 GMT
 design therapeutics appoints justin gover to board of directors  The Globe and Mail Wed, 10 Sep 2025 20:01:00 GMT
 xenon (xene) receives a buy from rbc capital  The Globe and Mail Wed, 03 Sep 2025 10:54:00 GMT
 published on: 2025-09-03 01:33:36  Newser Wed, 03 Sep 2025 06:33:36 GMT
 published on: 2025-08-31 21:29:33  Newser Mon, 01 Sep 2025 02:29:33 GMT
 published on: 2025-08-29 19:36:10  Newser Sat, 30 Aug 2025 00:36:10 GMT
 published on: 2025-08-29 17:07:32  Newser Fri, 29 Aug 2025 22:07:32 GMT
 published on: 2025-08-26 14:28:29  Newser Tue, 26 Aug 2025 19:28:29 GMT
 published on: 2025-08-26 02:49:01  Newser Tue, 26 Aug 2025 07:49:01 GMT
 published on: 2025-08-25 08:56:05  Newser Mon, 25 Aug 2025 13:56:05 GMT

Xenon Pharmaceuticals Inc
(NASDAQ:XENE) 

XENE stock logo

Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel modulator that is Phase III clinical trials for the treatment...

Founded: 1996
Full Time Employees: 100
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends